Could stem cells tame brain inflammation? new study tracks Real-World results
NCT ID NCT07145502
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 76 people with autoimmune or post-infection brain inflammation who are receiving stem cell or exosome treatments. Researchers will track changes in symptoms, inflammation markers, and quality of life. The goal is to see if these experimental therapies can help when standard treatments have failed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stem cells and exosomes
- What this could lead to
- If successful, this could point toward a new way to manage hard-to-treat brain inflammation conditions like autoimmune encephalitis.
- What could go wrong
- This is an early observational study with no control group, so results may not prove the treatment works. Risks include reactions to the infusions and uncertainty about long-term benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biocells Medical
Warsaw, 01-234, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can we predict who will relapse after brain inflammation?
- New study tracks pregnancy in women with neuroimmune diseases
- New study uses advanced scans to map brain inflammation over time
- Could Immune-Boosting drugs treat certain psychosis?
- New antibody drug aims to block Brain-Attacking autoantibodies